Ameriderm Laboratories, Ltd. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Feb 13, 2013
  • Last warning letter 2013
Inspections 2 1 OAI
Recalls 0 0 Class I
Warning letters 1 Latest Dec 2, 2013
510(k) clearances 0 None on file

Ameriderm Laboratories, Ltd. has 0 FDA recalls, 2 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Ameriderm Laboratories, Ltd., the most recent on Dec 2, 2013.

What these totals cover: FDA records filed under the name "Ameriderm Laboratories, Ltd." and its spelling variant "Ameriderm Laboratories".

Latest inspection
Feb 13, 2013 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections2Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Ameriderm Laboratories, Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Ameriderm Laboratories, Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Ameriderm Laboratories, Ltd. FDA Warning Letters

1 warning letter on Dec 2, 2013.

IssuedSubjectIssuing officeClose-out letter
Dec 2, 2013 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

2 inspections from Jun 29, 2011 to Feb 13, 2013.

DateSiteProductClassificationFEI
Feb 13, 2013Paterson, NJDrugsOfficial Action Indicated (OAI)3001452902
Jun 29, 2011Paterson, NJDrugsVoluntary Action Indicated (VAI)3001452902
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Ameriderm Laboratories, Ltd.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Dec 2, 2013.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3001452902Paterson, NJ2Feb 13, 2013

Ameriderm Laboratories, Ltd. and the FDA: common questions

Has Ameriderm Laboratories, Ltd. received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Ameriderm Laboratories, Ltd.. The most recent is dated Dec 2, 2013.

Has Ameriderm Laboratories, Ltd. received an FDA Form 483?

FDA has not published a Form 483 for "Ameriderm Laboratories, Ltd." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Ameriderm Laboratories, Ltd.?

The most recent FDA inspection on file ended Feb 13, 2013 at Paterson, NJ and was classified OAI. FDA has 2 inspections of Ameriderm Laboratories, Ltd. on file, 1 of them classified OAI (official action indicated).

Need more than this page shows? Ask about Ameriderm Laboratories, Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.